PD-1 restrains IL-17A production from γδ T cells to modulate acute radiation-induced lung injury

BACKGROUND: Combining radiotherapy (RT) with programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) inhibitors has been shown to enhance anti-tumor effects in the treatment of non-small cell lung carcinoma (NSCLC). Pulmonary toxicity is a major adverse effect of thoracic RT in NSCLC patients, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Yuling, Chen, Kun, Jiang, Wei, Wu, Zhiyuan, Zhang, Wenjue, Jing, Hao, Wang, Luhua, Qu, Chunfeng, Ren, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947382/
https://www.ncbi.nlm.nih.gov/pubmed/33718014
http://dx.doi.org/10.21037/tlcr-20-838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947382/
https://www.ncbi.nlm.nih.gov/pubmed/33718014
http://dx.doi.org/10.21037/tlcr-20-838

Ejemplares similares